» Articles » PMID: 8862503

Transfection with the CDNA of the Human Thyrotropin Receptor of a Poorly Differentiated Rat Thyroid Cell Line (FRT)

Overview
Publisher Springer
Specialty Endocrinology
Date 1996 Apr 1
PMID 8862503
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A cell line derived from the Fisher rat thyroid (FRT), that does not have functional TSH receptor, was stably transfected with the cDNA of the human TSH receptor (h TSH-R). In wild FRT cells TSH (1-1000 mU/l) was unable to increase cAMP production, while 10-10000 nmol/l forskolin elicited a 10-30 fold cAMP stimulation. Two of the transfected clones were responsive to TSH in terms of cAMP production. In particular, the FRT-R3 transfected clone showed the highest sensitivity to the hormone with a 10 fold cAMP increase over the basal at 100 mU/l TSH. The Northern blot analysis using a 2.4 kbp cDNA probe for the hTSH-R showed a band corresponding to the mRNA of TSH receptor in FRT-R3 cells, but not in wild FRT cells. In both cell types TSH was ineffective in stimulating growth assayed by 3H-thymidine incorporation into DNA. Hybridization with a probe for thyroperoxidase on polymerase chain reaction products after reverse transcription of mRNA showed that FRT-R3, as well as FRT cells, do not have a transcript for thyroperoxidase. In conclusion, the data reported in this paper show that the insertion of the hTSH-R cDNA in the genome of poorly differentiated rat thyroid cells results in the recovery of TSH-dependent adenylate cyclase, but not other differentiated thyroid cell functions.

Citing Articles

Asynchrony of Apical Polarization, Luminogenesis, and Functional Differentiation in the Developing Thyroid Gland.

Johansson E, Liang S, Moccia C, Carlsson T, Andersson D, Fagman H Front Endocrinol (Lausanne). 2022; 12:760541.

PMID: 34975747 PMC: 8719337. DOI: 10.3389/fendo.2021.760541.


Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer.

Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C Onco Targets Ther. 2016; 9:6467-6477.

PMID: 27799794 PMC: 5079697. DOI: 10.2147/OTT.S84625.

References
1.
Garbi C, Mascia A, Nitsch L . Cell polarity and morphogenetic properties of Fischer rat thyroid cells (FRT) cultured in suspension or embedded in different gels. Cell Mol Biol. 1987; 33(3):293-305. View

2.
Chiovato L, Vitti P, Santini F, Lopez G, Mammoli C, Bassi P . Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 1990; 71(1):40-5. DOI: 10.1210/jcem-71-1-40. View

3.
Chiovato L, Vitti P, Bendinelli G, Santini F, Fiore E, Capaccioli A . Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor. J Endocrinol Invest. 1994; 17(10):809-16. DOI: 10.1007/BF03347782. View

4.
Ludgate M, Perret J, Parmentier M, Gerard C, Libert F, Dumont J . Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies. Mol Cell Endocrinol. 1990; 73(1):R13-8. DOI: 10.1016/0303-7207(90)90050-i. View

5.
Chiovato L, Vitti P, Lombardi A, Ceccarelli P, Cucchi P, Marcocci C . Studies on the mechanism responsible for thyrotropin-induced expression of microsomal/peroxidase antigen in FRTL-5 cells. Endocrinology. 1988; 123(2):1140-6. DOI: 10.1210/endo-123-2-1140. View